Related Experiment Videos
Multiple meningiomas
A Leondi1, V Valotassiou, J Koutsikos
1Nuclear Medicine Department, Alexandra University Hospital, Athens, Greece. jtkoutsik@yahoo.gr
Clinical Nuclear Medicine
|April 14, 2005
Summary
Somatostatin receptor scintigraphy detected abnormal radiotracer uptake in a patient with hyperthyroid ophthalmopathy, leading to the discovery of multiple meningiomas. This imaging technique aids in diagnosing rare neurological conditions.
Area of Science:
- Nuclear medicine imaging
- Neuro-oncology
Background:
- Hyperthyroid ophthalmopathy can present with varied symptoms.
- Somatostatin receptor scintigraphy is used to visualize somatostatin receptor-expressing tissues.
Observation:
- A patient with hyperthyroid ophthalmopathy and headaches underwent In-111 pentetreotide scintigraphy.
- The scan showed increased radiotracer uptake in periorbital areas, the thyroid, and the right side of the head.
Findings:
- Brain MRI revealed multiple lesions consistent with meningiomas on the right cerebral hemisphere.
- The scintigraphy findings correlated with the presence of meningiomas.
Implications:
- Somatostatin receptor scintigraphy may reveal unexpected neurological findings.
- This case highlights the potential of nuclear imaging in identifying non-thyroidal pathologies.
- Further investigation into the association between ophthalmopathy and meningioma presentation is warranted.